Sudair Pharmaceutical Company
Mohamed Azzouz is a seasoned professional in the pharmaceutical industry with over a decade of experience, currently serving as Medical Affairs Manager at Sudair Pharmaceutical Company since May 2019, covering various disease areas including Oncology, Hematology, Neuroscience, Pulmonary Hypertension, and Anti-coagulation. Previously, Mohamed worked at Roche from March 2012 to April 2019 as a Medical Science Liaison focusing on cancer immunotherapy, personalized healthcare, and addressing medical knowledge gaps in solid tumors. Mohamed began their career at Abbott and APEX Multi-APEX Pharma as a Medical Representative, promoting gastrointestinal, gynecological, orthopedics, and dermatological products. Mohamed holds a Bachelor of Pharmacy from Alexandria University, Egypt.
This person is not in any teams
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.